December 5, 2022 — With AI becoming an integral part of clinical radiology workflows, the data used to develop AI algorithms is ever essential. An identified industry challenge is ensuring post-market surveillance of AI at scale, providing a foundation for the continued clinical safety and improvement of algorithms before and after clinical deployment. AI algorithms already need to meet high-performance standards for clearance by notified bodies such as the FDA.
December 5, 2022 — IMV, part of Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2022 IMV ServiceTrak Imaging Awards.
December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced topline results from its Phase 3 LIGHTHOUSE trial that evaluated the diagnostic performance and safety of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer. 18F-rhPSMA-7.3 is an investigational high affinity radiohybrid (rh) Prostate-Specific Membrane Antigen-targeted PET imaging agent.
December 2, 2022 — New CT technology outperforms conventional CT in detecting subtle damage in the lungs of patients with persistent symptoms of COVID-19, according to a new study published in
December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass surgery is more effective than the angiogram, which is currently used, according to research from UTHealth Houston Heart & Vascular.
